Ocera gets bullish coverage at Stifel, shares rise

Shares of Ocera Therapeutics (OCRX +5.8%) are notably higher in early trading.

Helping the cause is Stifel, where analysts have initiated coverage at Buy.

Price target is $19, representing upside of 62% from Friday's close.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs